Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G

10.1136/ard.60.11.1040

10.1016/S0950-3579(94)80017-0

10.1016/S0140-6736(10)60826-4

Braun J Pincus T . Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 2002;20:S16-22.

10.1136/ard.62.9.897

10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N

10.1136/ard.52.3.174

Sokka T Abelson B Pincus T . Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26:S35-61.

10.1002/art.1780401021

10.1136/ard.2011.151191

10.3899/jrheum.090481

10.1002/art.10905

10.1136/ard.2004.032482

10.1002/art.1780270805

Descalzo MA Carbonell J Gonzalez-Alvaro I . Effectiveness of a clinical practice intervention in early rheumatoid arthritis. Arthritis Care Res 2012;64:321-30.

10.1002/art.21405

10.1136/annrheumdis-2012-201456

10.1016/S0140-6736(04)16676-2

10.1016/S0140-6736(98)08513-4

10.1093/rheumatology/keh199

10.1002/art.10092

10.1016/j.rdc.2012.08.001

10.1136/ard.2007.071092

10.1007/s00296-013-2772-6

10.1503/cmaj.091391

10.1136/ard.2011.150995

10.1136/ard.2006.067660

10.1136/ard.2009.125658

10.1002/art.11137

Pena-Sagredo JL Farinas MC Perez-Zafrilla B . Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy. Clin Exp Rheumatol 2009;27:920-5.

Pena-Sagredo JL Hernandez MV Fernandez-Llanio N . Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. Clin Exp Rheumatol 2008;26:854-9.

10.1016/j.medcli.2010.11.032

10.1002/art.21043

10.1016/j.reuma.2011.05.002

10.1186/1479-5876-9-S2-P44

10.1007/s10067-011-1722-5

Escudero-Vilaplana V Ramirez-Herraiz E Trovato-Lopez N . Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis. J Pharm Pharm Sci 2012;15:355-60.

Ramirez-Herraiz E Escudero-Vilaplana V Alanon-Plaza E . Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice. Clin Exp Rheumatol 2013;31:559-65.

Ramírez Herráiz E Escudero Villaplana V Alañón Plaza E . Uso real de antagonistas del TNF en la práctica clínica: Optimización de dosis y costes asociados en pacientes con Espondilitis Anquilosante en 2 hospitales generales universitarios. Reumatol Clin 2013;9:26-7.

Maneiro JR Perez-Pampin E Salgado E Carmona L Gomez-Reino JJ . Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience. Rheumatol Int 2014;37:1059-63.

Inciarte-Mundo J Hernandez MV Rosario V . Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions. Reumatol Clin 2013;10:10-6.

10.1136/annrheumdis-2013-204573

10.1016/j.jbspin.2011.12.004

10.1056/NEJM200011303432202

10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W

10.1002/art.22033

10.1002/art.20221

10.1136/annrheumdis-2011-200702

10.1002/art.27555

10.1093/rheumatology/kes305

Ortún Rubio V . ¿Qué debería saber un clínico de Economía? [What should a doctor know about economy?]. In: Millan Núñez-Cortes J del Llano Señarís JE , editors. Ser médico Los valores de una profesión [Being a doctor: The values of a profession]. Alcobendas, Madrid (Spain): Unión Editorial, SA; 2012.

den Broeder A van de Putte L Rau R . A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis. J Rheumatol 2002;29:2288-98.

European Medicines Agency. London: EMA; 2010. Assessment Report For Mabthera (rituximab): Procedure No.: EMEA/H/C/000165/II/0065.

10.1177/0091270009350623

10.1345/aph.19126

Nishimoto N Yoshizaki K Maeda K . Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study. J Rheumatol 2003;30:1426-35.

10.1002/art.10302

Sociedad Española de Reumatología. Proyecto EMAR II. Variabilidad en el manejo de la artritis reumatoide y las espondiloartritis en España. Informe de resultados. Madrid: SER, 2011 [updated February 2011]. http://www.ser.es/ArchivosDESCARGABLES/Proyectos/Emar/EMAR_Informe.pdf (5 September 2013, date last accessed).

Fitch K . Santa Monica: Rand; 2001. The Rand/UCLA appropriateness method user’s manual.

Scottish Intercollegiate Guidelines Network. A guideline developer’s handbook: SIGN 50. Edinburgh: SIGN (NHS Quality Improvement Scotland), 2008. http://www.intute.ac.uk/healthandlifesciences/cgi-bin/fullrecord.pl?handle=20080207-11330481 (28 August 2013, date last accessed).

10.1016/0197-2456(95)00134-4

10.1136/ard.2009.117341

10.1136/ard.2009.121491

10.1016/S0140-6736(12)61811-X

10.1136/annrheumdis-2011-200945

10.1016/j.jbspin.2008.11.009

10.1186/ar1693

10.1136/annrheumdis-2011-201252

10.1002/art.21054

10.1002/art.10883

10.1136/annrheumdis-2012-201766

10.1136/annrheumdis-2012-202389

10.1136/ard.2007.071605

10.1002/art.20712

10.1136/ard.2010.147751

Bresnihan B Newmark R Robbins S Genant HK . Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial. J Rheumatol 2004;31:1103-11.

St Clair EW Heijde DM Smolen JS . Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;11:3432-43.

10.1002/art.30263

10.1093/rheumatology/kes082

10.1002/art.30158

10.1002/art.20159

10.1093/rheumatology/kes188

10.1136/annrheumdis-2011-200170

10.1136/ard.2004.033472

10.1136/annrheumdis-2012-202698

10.1136/ard.2008.100438

10.1093/rheumatology/ker253

10.1136/annrheumdis-2013-203480

10.1136/annrheumdis-2012-201956

10.1093/rheumatology/ker417

10.1002/acr.22116

10.1002/art.30152

10.1136/bmjopen-2012-001524

10.1136/annrheumdis-2011-200337

10.1158/0008-5472.CAN-03-2862